$Avalo Therapeutics Inc(AVTX)$AVTX Long and strong from last summer, held through the r/s, and then added. note to newbies: pay no attention to these real-looking price targets. They’re phony, fabricated by posters. I could post a $300 PT, but why? It’s gonna do what it’s gonna do.
$Avalo Therapeutics Inc(AVTX)$People profit by making people convinced that the stock will go down, you have an incentive to say this.don't act like you are more accurate and correct, you are also here for financial gain just like the rest of us, of course we promote the stock in a way for our personal benefitand here's the thing, I previously based my theory on statistics & factsyou are basing off of news only chap, you have no solid basis for what you are saying.
$Avalo Therapeutics Inc(AVTX)$Is anyone selling tomorrow if do what do u think is a good high selling price? or should I hold? By the way, any thoughts on a high side selling price ? additionally, Of course there is always a short bear monitoring the comment section, watch me I will get 1 dislike. Judge the stock by analysing & looking at facts, not by your upside down ego!
$Avalo Therapeutics Inc(AVTX)$Counter-intuitive to what folks generally think, even if we get increased shares in circulation in the future it will not really crash the share price because all the shares will simply be held in storage by the investment companies involved, they wont be actively traded (bought & sold) as part of the float, simply just being hold onto, having no direct effect on the share price and price movement.
$Avalo Therapeutics Inc(AVTX)$Now I have made a forecast."Counter-intuitive to what folks generally think, even if we get increased shares in circulation in the future it will not really crash the share price because all the shares will simply be held in storage by the investment companies involved, they wont be actively traded (bought & sold) as part of the float, simply just being hold onto, having no direct effect on the share price and price movement."Based on factsI think what's going to happen on Monday is totally different from what people in this comment section expect, you just kind of have to understand the sentiment and the theoretical sideMy forecast:Pre-market: buying pressure, possible short squeeze.At
I think it's undervalued because if you divide the amount of the private placement which is $185 million with the number of outstanding shares which are around 800 thousand, then you have 235 dollars per share!This private placement generates a value of 235 dollars per share, this is crazy!According to this weird fact I think it will go up much higher. $Avalo Therapeutics Inc(AVTX)$
The autoimmune disease indications, are a great and completely un-met challenge for pharmaceutical companies. It’s a field in which they haven’t even caused a dent in solving the puzzle. Any hope to “break the code” on these illnesses would be welcome. It’s about time . $Avalo Therapeutics Inc(AVTX)$
Market cap right now $30 M …. Private equity placement of $175M … that’s 6x market cap….. this should be at $180-$200 per share …. Market makers know this so no one is going to sell. Next week will be exciting. GL $Avalo Therapeutics Inc(AVTX)$
Smart investors got out at $33. how can any stock go up 600% in a day and stay there? not even NVDA or AMD. do look at the stocks that went up 500% in a day like PRST and VERB they hit the bottom next day. it's pump and dump. $Avalo Therapeutics Inc(AVTX)$
Considering how few shares are in circulation at the moment, I think this stock could reach $40 dollars very well. Considering the massive, great volatility, it could even go to 50+, or even 80 like Viking Therapeutics. They might dilute it later, but that isn't a problem, most will probably be selling once it goes to around 40. It will likely do so next week, we are going to wait and see folks. There are only 801k shares in circulation, Avalo stock is still under high demand after that news so we should get another run-up, the volatility of a microcap makes 100% runs perfectly achievable. Back in 2023 this stock was crazy, 100% in a day was an expected thing, it was a penny stock almost. They had to sell off a part of their pipeline for cash. And that's when the
Bullish Points: 1. Net loss for the three months ended June 30, 2023, was $8,193,000, compared to a net loss of $12,987,000 for the same period in 2022. 2. Net loss for the six months ended June 30, 2023, was $18,148,000, compared to a net loss of $35,038,000 for the same period in 2022. 3. Basic and diluted net loss per share for the three months ended June 30, 2023, was $0.59, compared to $1.38 for the same period in 2022. 4. Basic and diluted net loss per share for the six months ended June 30, 2023, was $1.41, compared to $3.73 for the same period in 2022. 5. Company entered into a license agreement with Kyowa Kirin Co., Ltd. (KKC) for exclusive worldwide rights to develop, manufacture, and commercialize AVTX-002. 6. Selling, general and administrative expenses decreased by $0.4 millio
Avalo Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation. The company's drug candidates include AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the treatment of non-eosinophilic asthma, as well as Crohn's disease; Phase III clinical trial for the treatment of COVID-19 acute respiratory distress syndrome; and AVTX-008, a fully human B and T Lymphocyte Attenuator (BTLA) agonist fusion protein. It also develops AVTX-803, a L-fucose monosaccharide therapy for treatment of Leukocyte Adhesion Deficiency Type II. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Rockville, Maryland.
04-23
Beneficial Ownership Change
Form SC 13G - Statement of acquisition of beneficial ownership by individuals